Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.32 -0.03 (-0.34%)
As of: Oct 22, 2026 · 3:59 PM EDT

Zevra Therapeutics (ZVRA) Long-Term Debt Issuances (2016 - 2024)

Updated

Zevra Therapeutics' Long-Term Debt Issuances came in at $58.99 million for FY2024, up 39.0% from $42.43 million in FY2023.

Analysis

Zevra Therapeutics (ZVRA) Long-Term Debt Issuances (2016 - 2024) Analysis & Trends

Going back to FY2013, Zevra Therapeutics' Long-Term Debt Issuances data covers 7 years.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of 194.8% (FY2020 to FY2024).
  • The FY2024 figure represents the highest annual Long-Term Debt Issuances since FY2016.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $42.43 million in FY2023 (+231.5%), $12.8 million in FY2022 and $781,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Zevra Therapeutics 612.26 Mn -200.44 Mn 38.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 58.99 Mn
Dec 31, 2023 3.63 Mn
Sep 30, 2023 26.00 Mn
Jun 30, 2023 -114,000.00
Mar 31, 2023 12.91 Mn
Jun 30, 2022 12.80 Mn
Mar 31, 2016 82.80 Mn
API Access

Zevra Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ZVRA&period=max&api_key=YOUR_API_KEY